Anti-il-22 antibodies, antibody fragments, their immunoconjugates and uses thereof

TW202626706APending Publication Date: 2026-07-01BIOATLA LLC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: TW114142896
Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2018-10-30
Filing Date: 2019-06-05
Publication Date: 2026-07-01

Application Information

Patent Timeline

30 Oct 2018

Priority

05 Jun 2019

Application

TW114142896

01 Jul 2026

Publication

TW202626706A

IPC: C07K16/18; A61K39/395; A61P37/00; C07K16/24

Inventors: 休特杰 M; 弗雷傑爾哈

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

An anti-IL-22 antibody or antibody fragment that binds to both human IL-22 and a mammalian IL-22 as well as modified anti-IL-22 antibodies and antibody fragments. Pharmaceutical compositions and kits comprising the antibody or antibody fragment are also provided. Also provided are methods for treatment of various IL-22 mediated conditions and diseases.

Need to check novelty before this filing date? Find Prior Art